+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Biobanks Market by Component (Consumables, Equipment, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989810
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biobanks Market size was estimated at USD 67.81 billion in 2023, USD 75.75 billion in 2024, and is expected to grow at a CAGR of 11.80% to reach USD 148.10 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biobanks Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biobanks Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biobanks Market, highlighting leading vendors and their innovative profiles. These include Acorn Biolabs, Inc., Artizan Biosciences, Inc., Bay Biosciences LLC, Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson and Company, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, Merck KGaA, ProteoGenex, Inc., Provia Laboratories, LLC, Shanghai Zhangjiang Biobank, Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., and UK Biobank Limited.

Market Segmentation & Coverage

This research report categorizes the Biobanks Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Consumables
    • Equipment
    • Services
    • Software
  • Sample Type
    • Biological Fluids
    • Blood Products
    • Cell Lines
    • Human Tissues
    • Nucleic Acids
  • Application
    • Clinical Research
    • Life Science Research
    • Regenerative Medicine
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Biobanks Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biobanks Market?
  3. What are the technology trends and regulatory frameworks in the Biobanks Market?
  4. What is the market share of the leading vendors in the Biobanks Market?
  5. Which modes and strategic moves are suitable for entering the Biobanks Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biobanks Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in incidence of chronic disease
5.1.1.2. Rising awareness about biobanks
5.1.1.3. Increasing population coupled with presence of a large geriatric population base
5.1.2. Restraints
5.1.2.1. Ethical and legal issues related to biobanking
5.1.3. Opportunities
5.1.3.1. Growing genomic research activities in economies
5.1.3.2. Increasing public awareness about genomic testing and stem cell therapies
5.1.4. Challenges
5.1.4.1. Long-Term Sustainability of Biobanks
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biobanks Market, by Component
6.1. Introduction
6.2. Consumables
6.3. Equipment
6.4. Services
6.5. Software
7. Biobanks Market, by Sample Type
7.1. Introduction
7.2. Biological Fluids
7.3. Blood Products
7.4. Cell Lines
7.5. Human Tissues
7.6. Nucleic Acids
8. Biobanks Market, by Application
8.1. Introduction
8.2. Clinical Research
8.3. Life Science Research
8.4. Regenerative Medicine
9. Americas Biobanks Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biobanks Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Biobanks Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Acorn Biolabs, Inc.
13.1.2. Artizan Biosciences, Inc.
13.1.3. Bay Biosciences LLC
13.1.4. Beckman Coulter, Inc. by Danaher Corporation
13.1.5. Becton, Dickinson and Company
13.1.6. BioLife Solutions Inc.
13.1.7. LVL Technologies GmbH & Co. KG
13.1.8. Merck KGaA
13.1.9. ProteoGenex, Inc.
13.1.10. Provia Laboratories, LLC
13.1.11. Shanghai Zhangjiang Biobank
13.1.12. Taylor-Wharton
13.1.13. Tecan Trading AG
13.1.14. Thermo Fisher Scientific Inc.
13.1.15. UK Biobank Limited
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BIOBANKS MARKET RESEARCH PROCESS
FIGURE 2. BIOBANKS MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOBANKS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOBANKS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOBANKS MARKET DYNAMICS
FIGURE 7. BIOBANKS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. BIOBANKS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 10. BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOBANKS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. BIOBANKS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BIOBANKS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 6. BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BIOBANKS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 11. BIOBANKS MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BIOBANKS MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BIOBANKS MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BIOBANKS MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. BIOBANKS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BIOBANKS MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BIOBANKS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 31. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 34. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 48. CHINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 51. INDIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 57. JAPAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 75. THAILAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 85. DENMARK BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 88. EGYPT BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 91. FINLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 94. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 103. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 112. NORWAY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 115. POLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. QATAR BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 130. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 139. TURKEY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 148. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 149. BIOBANKS MARKET LICENSE & PRICING

Companies Mentioned

  • Acorn Biolabs, Inc.
  • Artizan Biosciences, Inc.
  • Bay Biosciences LLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • BioLife Solutions Inc.
  • LVL Technologies GmbH & Co. KG
  • Merck KGaA
  • ProteoGenex, Inc.
  • Provia Laboratories, LLC
  • Shanghai Zhangjiang Biobank
  • Taylor-Wharton
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited

Methodology

Loading
LOADING...

Table Information